In a groundbreaking move, the U.S. Food and Drug Administration (FDA) has recently granted full approval to Leqembi (pronounced lah-kem-be), a potential game-changing drug for the treatment of Alzheimer's disease. Unlike previously approved medications that primarily focused on managing the symptoms of this debilitating condition. . .
FDA Approves Revolutionary Alzheimer’s Drug, Leqembi, Shaking Up the Medical Field
Leqembi is the first drug to demonstrate the ability to slow the progression of memory loss associated with Alzheimer's disease